Pharvaris announced abstract acceptances for the 2025 National Summit on hereditary angioedema, featuring multiple poster presentations on deucrictibant.

The antibody-based drug Andembry is the first to target factor XIIa, a protein responsible for swelling in people with this rare genetic disorder.

Sivem Pharmaceuticals ULC is recalling one lot of Sivem ezetimibe 10 mg tablets because some bottles may also contain perindopril 4 mg tablets. Taking perindopril when prescribed ezetimibe may ...

Pharvaris announces acceptance of abstracts for upcoming congresses, showcasing research on oral bradykinin B2 receptor antagonists and angioedema.

Given the history of recurrent episodes of angioedema, the absence of laboratory findings suggestive of hereditary angioedema, and the temporal association with ACE inhibitor use, the clinical ...

Hereditary angioedema is characterized by unpredictable swelling involving the face, oropharynx, extremities, or abdomen, without hives or pruritus. Laryngeal attacks carry a risk of asphyxiation, ...

Hereditary angioedema usually starts in childhood and goes undiagnosed because of poor awareness among patients and doctors alike.

Because HAE, a rare genetic disorder, is so rare and because swelling can be a nonspecific symptom, many cases are initially missed or misdiagnosed, leading to delays in diagnosis.

For adults with hereditary angioedema, the in vivo gene-editing therapy NTLA-2002, administered as a single dose reduces angioedema attacks.

A single dose of the CRISPR-based gene-editing therapy NTLA-2002 reduced angioedema attacks and led to sustained reduction in total plasma kallikrein protein levels compared with placebo in ...

Hereditary angioedema (HAE) is a genetic condition featuring episodes of painful, rapid swelling under the skin. Stress is one of the most common triggers of HAE.